skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Oncology remover Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Stage IV endometrial carcinoma: A clinical and histopathological study of 83 patients
Stage IV endometrial carcinoma: A clinical and histopathological study of 83 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stage IV endometrial carcinoma: A clinical and histopathological study of 83 patients

Aalders, J.G. ; Abeler, V. ; Kolstad, P.

Gynecologic oncology, 1984, Vol.17 (1), p.75-84 [Periódico revisado por pares]

San Diego, CA: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients
Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients

Aalders, J.G. ; Abeler, V. ; Kolstad, P.

Gynecologic oncology, 1984, Vol.17 (1), p.64-74 [Periódico revisado por pares]

San Diego, CA: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial

Aalders, K.C ; Kuijer, A ; Straver, M.E ; Slaets, L ; Litiere, S ; Viale, G ; van't Veer, L.J ; Glas, A.M ; Delorenzi, M ; van Dalen, T ; Tryfonidis, K ; Piccart, M.J ; Cardoso, F ; Rutgers, E.J

European journal of cancer (1990), 2017-07, Vol.79, p.98-105 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma
Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma

Aaltomaa, S ; Lipponen, P ; Eskelinen, M ; Kosma, V M ; Marin, S ; Alhava, E ; Syrjänen, K

Anticancer research, 1991-09, Vol.11 (5), p.1701 [Periódico revisado por pares]

Greece

Sem texto completo

Citações Citado por
5
Prognostic value of cathepsin-D expression in female breast cancer
Prognostic value of cathepsin-D expression in female breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic value of cathepsin-D expression in female breast cancer

Aaltonen, M ; Lipponen, P ; Kosma, V M ; Aaltomaa, S ; Syrjänen, K

Anticancer research, 1995-05, Vol.15 (3), p.1033 [Periódico revisado por pares]

Greece

Sem texto completo

Citações Citado por
6
The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?
The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?
Material Type:
Artigo 		Adicionar ao Meu Espaço

The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

Aapro, Matti ; De Laurentiis, Michelino ; Rea, Dan ; Bargallo Rocha, Juan Enrique ; Elizalde, Roberto ; Landherr, László ; Linderholm, Barbro ; Mamounas, Eleftherios ; Markopoulos, Christos ; Neven, Patrick ; Petrovsky, Alexander ; Rouzier, Roman ; Smit, Vincent ; Svedman, Christer ; Schneider, Daniel ; Thomssen, Christoph ; Martin, Miguel

Breast (Edinburgh), 2017-06, Vol.33, p.191-199 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers
Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers

Abd El-Hafez, Amal ; Shawky Mohamed, Abd El-Aty ; Elesawy, Basem Hasan

Asian Pacific journal of cancer prevention : APJCP, 2013-01, Vol.14 (2), p.1037-1041 [Periódico revisado por pares]

Thailand

Texto completo disponível

Citações Citado por
8
StAR and progesterone producing enzymes (3β‐hydroxysteroid dehydrogenase and cholesterol side‐chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: Immunohistochemical and real‐time PCR studies
StAR and progesterone producing enzymes (3β‐hydroxysteroid dehydrogenase and cholesterol side‐chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: Immunohistochemical and real‐time PCR studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

StAR and progesterone producing enzymes (3β‐hydroxysteroid dehydrogenase and cholesterol side‐chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: Immunohistochemical and real‐time PCR studies

Abd‐Elaziz, Manar ; Moriya, Takuya ; Akahira, Jun‐ichi ; Suzuki, Takashi ; Sasano, Hironobu

Cancer science, 2005-04, Vol.96 (4), p.232-239 [Periódico revisado por pares]

Oxford, UK: Blackwell Science Pty

Texto completo disponível

Citações Citado por
9
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

Abdel-Fatah, T.M.A. ; Perry, C. ; Dickinson, P. ; Ball, G. ; Moseley, P. ; Madhusudan, S. ; Ellis, I.O. ; Chan, S.Y.T.

Annals of oncology, 2013-11, Vol.24 (11), p.2801-2807 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors

Abdel-Maksoud, Madiha F. ; Risendal, Betsy C. ; Slattery, Marty L. ; Giuliano, Anna R. ; Baumgartner, Kathy B. ; Byers, Tim E.

Breast cancer research and treatment, 2012-01, Vol.131 (1), p.169-176 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (4.165)
  2. Revistas revisadas por pares (4.375)

Data de Publicação 

De até
Refinar
  1. Antes de1981  (52)
  2. 1981Até1991  (355)
  3. 1992Até2002  (700)
  4. 2003Até2014  (2.269)
  5. Após 2014  (1.245)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (4.612)
  2. Japonês  (695)
  3. Russo  (10)
  4. Francês  (8)
  5. Norueguês  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.